Diabetic renal disease in African Americans

被引:27
作者
Crook, ED
机构
[1] Wayne State Univ, Sch Med, Detroit, MI 48202 USA
[2] John D Dingell VA Med Ctr, Detroit, MI USA
关键词
African American; diabetic nephropathy; end-stage renal disease; hypertension; diabetes mellitus type 2;
D O I
10.1097/00000441-200202000-00004
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Diabetic nephropathy (DN) is the No. I cause of end-stage renal disease in the United States and is highly prevalent in African Americans. Almost all DN in African Americans is caused by type 2 diabetes. Glycemic control and control of blood pressure are essential to prolong renal survival and to protect against cardiovascular events. Among African Americans, diabetic nephropathy seems to affect women more than men, which may be related to increased rates of obesity and diabetes in African American women. In addition to gender, the development of albuminuria, family history, and possibly birth weight are factors that predict progression of renal disease in African Americans with DN. The impact of glycemic control, appropriate antihypertensives, and the optimal level of blood pressure control in African Americans with advanced DN require further study. This article will review the clinical characteristics, risk factors, predictors of disease progression, and treatment of diabetic nephropathy in African Americans.
引用
收藏
页码:78 / 84
页数:7
相关论文
共 59 条
  • [31] Serum creatinine levels in the US population: Third National Health and Nutrition Examination Survey
    Jones, CA
    McQuillan, GM
    Kusek, JW
    Eberhardt, MS
    Herman, WH
    Coresh, J
    Salive, M
    Jones, CP
    Agodoa, LY
    [J]. AMERICAN JOURNAL OF KIDNEY DISEASES, 1998, 32 (06) : 992 - 999
  • [32] THE EFFECTS OF DIETARY-PROTEIN RESTRICTION AND BLOOD-PRESSURE CONTROL ON THE PROGRESSION OF CHRONIC RENAL-DISEASE
    KLAHR, S
    LEVEY, AS
    BECK, GJ
    CAGGIULA, AW
    HUNSICKER, L
    KUSEK, JW
    STRIKER, G
    BUCKALEW, V
    BURKART, J
    FURBERG, C
    FELTS, J
    MOORE, M
    ROCCO, H
    DOLECEK, T
    WARREN, S
    BEARDEN, B
    STARKEY, C
    HARVEY, J
    POOLE, D
    DAHLQUIST, S
    DOROSHENKO, L
    BRADHAM, K
    WEST, D
    AGOSTINO, J
    COLE, L
    BAKER, B
    HAIRSTON, K
    BURGOYNE, S
    LAZARUS, J
    STEINMAN, T
    SEIFTER, J
    DESMOND, M
    FIORENZO, M
    CHIAVACCI, A
    METALIDES, T
    KORZECRAMIREZ, D
    GOULD, S
    PICKETT, V
    PORUSH, J
    FAUBERT, P
    SPITALEWITZ, S
    FAUBERT, J
    ZIMMER, G
    SAUM, D
    BLOCK, M
    WOEL, J
    ROSE, M
    DENNIS, V
    SCHWAB, S
    MINDA, S
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 1994, 330 (13) : 877 - 884
  • [33] Risk factors for microalbuminuria in Black Americans with newly diagnosed type 2 diabetes
    Kohler, KA
    McClellan, WM
    Ziemer, DC
    Kleinbaum, DG
    Boring, JR
    [J]. AMERICAN JOURNAL OF KIDNEY DISEASES, 2000, 36 (05) : 903 - 913
  • [34] Konen Joseph C., 1999, Ethnicity and Disease, V9, P3
  • [35] A community-based study of explanatory factors for the excess risk for early renal function decline in blacks vs whites with diabetes - The atherosclerosis risk in communities study
    Krop, JS
    Coresh, J
    Chambless, LE
    Shahar, E
    Watson, RL
    Szklo, M
    Brancati, FL
    [J]. ARCHIVES OF INTERNAL MEDICINE, 1999, 159 (15) : 1777 - 1783
  • [36] Effect of ACE inhibitors in diabetic and nondiabetic chronic renal disease: A systematic overview of randomized placebo-controlled trials
    Kshirsagar, AV
    Joy, MS
    Hogan, SL
    Falk, RJ
    Colindres, RE
    [J]. AMERICAN JOURNAL OF KIDNEY DISEASES, 2000, 35 (04) : 695 - 707
  • [37] CROSS-SECTIONAL ANALYSIS OF RENAL-FUNCTION IN BLACK-AMERICANS WITH NIDDM
    LEBOVITZ, HE
    PALMISANO, J
    [J]. DIABETES CARE, 1990, 13 (11) : 1186 - 1190
  • [38] THE EFFECT OF ANGIOTENSIN-CONVERTING ENZYME-INHIBITION ON DIABETIC NEPHROPATHY
    LEWIS, EJ
    HUNSICKER, LG
    BAIN, RP
    ROHDE, RD
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 1993, 329 (20) : 1456 - 1462
  • [39] Randomised controlled trial of dual blockade of renin-angiotensin system in patients with hypertension, microalbuminuria, and non-insulin dependent diabetes: the candesartan and Lisinopril microalbuminuria (CALM) study
    Mogensen, CE
    Neldam, S
    Tikkanen, I
    Oren, S
    Viskoper, R
    Watts, RW
    Cooper, ME
    [J]. BMJ-BRITISH MEDICAL JOURNAL, 2000, 321 (7274): : 1440 - 1444
  • [40] Diabetes mellitus in older African-Americans, Hispanics, and whites in an academic hospital-based geriatrics practice
    Ness, J
    Nassimiha, D
    Feria, MI
    Aronow, WS
    [J]. CORONARY ARTERY DISEASE, 1999, 10 (05) : 343 - 346